Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
REGN
Stock Latest News
The Fly
Early notable gainers among liquid option names on October 1st
7d ago
AES
IQV
Premium
Market News
These 3 “Strong Buy” Value Stocks Have over 30% Upside, According to Analysts – 9/30/2025
8d ago
ALK
NOMD
Premium
The Fly
Regeneron announces U.S. FDA approved Evkeeza ANGPTL3 antibody
12d ago
REGN
Premium
Ratings
Positive Outlook on Regeneron Amidst EYLEA Challenges: Strategic Focus on GLP-1 Therapies for Alzheimer’s
12d ago
REGN
Premium
Market News
Scholar Rock Stock (SRRK) Puts on the Pounds Despite Muscle Drug Blow
15d ago
NVO
REGN
Premium
The Fly
Humana initiated, Paycom upgraded: Wall Street’s top analyst calls
16d ago
R
EG
Premium
The Fly
Regeneron, Sanofi announce CHMP opinion recommending Dupixent approval
16d ago
SNY
REGN
Premium
The Fly
Regeneron donates ebola treatment for use in countries at risk of outbreaks
19d ago
REGN
Premium
The Fly
Regeneron announces updated analyses from Phase 2 COURAGE trial
21d ago
REGN
Premium
The Fly
Regeneron announces primary endpoint met in Phase 3 OPTIMA trial
21d ago
REGN
Premium
Ratings
Buy Rating for Regeneron Amid Promising Allergy Treatment Trials and Strong Oncology Prospects
29d ago
REGN
Premium
The Fly
Regeneron announces follow-up results on Phase 3 EMPOWER-Lung 3 trial
29d ago
REGN
Premium
The Fly
Sandoz reaches agreement with Regeneron over patent litigation
29d ago
REGN
Premium
The Fly
Regeneron announces results of Phase 3 trials on allergen-blocking antibodies
1M ago
REGN
Premium
Company Announcements
Regeneron’s Innovative Cancer Study: A Potential Game-Changer for Advanced Tumors
1M ago
REGN
Premium
Company Announcements
Regeneron Advances Melanoma Treatment with Long-term Study Update
1M ago
REGN
Premium
Company Announcements
Regeneron’s Latest Clinical Study on Advanced NSCLC: A Potential Game Changer?
1M ago
REGN
Premium
Company Announcements
Regeneron’s Promising NSCLC Study: A Game Changer in Cancer Treatment?
1M ago
REGN
Premium
Company Announcements
Regeneron and Intellia’s Phase 3 Study on NTLA-2001: A Potential Game-Changer for Genetic Disorders
1M ago
REGN
Premium
Company Announcements
Regeneron’s Phase 2 Melanoma Study: A Potential Game-Changer in Cancer Treatment
1M ago
REGN
Premium
Company Announcements
Regeneron’s Linvoseltamab: A Promising Study for High-Risk Multiple Myeloma
1M ago
REGN
Premium
Company Announcements
Regeneron’s Linvoseltamab Study: A Potential Game-Changer in Multiple Myeloma Prevention
1M ago
REGN
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
